Happy news: we have seen a boost in randomizations in the @ALIFE2trial. Women with recurrent #miscarriage and #thrombophilia are allocated to #LMWH or standard of care. Lots of new #pregnancies and hope after lockdown 🥰 https://t.co/VUarBPf8SA @INVENT_VTE https://t.co/oTY9zupWvS
Happy news: we have seen a boost in randomizations in the @ ALIFE2trial. Women with recurrent #miscarriage and #thrombophilia are Allocated to #LMWH or standard of care. Lots of new #pregnancies and hopefully after lockdown 🥰 https://t.co/VUarBPf8SA @INVENT_VTE https://t.co/oTY9zupWvS
Fighting venous thromboembolism. Research on women, pregnancy. Internist, Prof Vascular Medicine, Amsterdam UMC. Council @ISTH. Past chair INVENT-VTE. Feminist.
Fighting venous thromboembolism. Research on women, pregnancy. Internist, Prof. Vascular Medicine, University Medical Center Amsterdam. Council @ISTH. Past chair INVENT-VTE. Feminist.